Saltar al contenido
Merck

71663

Fosfato de sodio dibasic dodecahydrate

tested according to Ph. Eur.

Sinónimos:

Fosfato de sec-sodio, Fosfato de disodio, Hidrogenofosfato de disodio dodecahydrate

Slide 1 of 1
Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

1 KG

US$ 148,00

US$ 148,00

PRECIOS SIN IMPUESTOS NACIONALES
Comprobar disponibilidad del carrito
Solicite una orden a granel

Acerca de este artículo

Fórmula lineal:
Na2HPO4 · 12H2O
Número CAS:
10039-32-4
Peso molecular:
358.14
EC Number:
231-448-7
MDL number:
MFCD00149181
UNSPSC Code:
12161700
PubChem Substance ID:
329763414
NACRES:
NA.25

Documentos clave

Ver Toda la documentación

Saltar a

Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

agency

tested according to Ph. Eur.

Quality Level

200

assay

98.5-102.5%

form

crystalline

solubility

water: ~35.8 g/L at 20 °C

SMILES string

O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O

InChI

1S/2Na.H3O4P.12H2O/c;;1-5(2,3)4;;;;;;;;;;;;/h;;(H3,1,2,3,4);12*1H2/q2*+1;;;;;;;;;;;;;/p-2

InChI key

DGLRDKLJZLEJCY-UHFFFAOYSA-L

¿Está buscando productos similares? Visita Guía de comparación de productos

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo
042737164971650
Fosfato de sodio dibasic dodecahydrate tested according to Ph. Eur.

Sigma-Aldrich

71663

Fosfato de sodio dibasic dodecahydrate

Fosfato de sodio dibasic dodecahydrate meets analytical specification of Ph. Eur., BP, E339, 98.5-102.5% (T)

Sigma-Aldrich

04273

Fosfato de sodio dibasic dodecahydrate

Fosfato de sodio dibasic dodecahydrate BioXtra, ≥99.0% (T)

Sigma-Aldrich

71649

Fosfato de sodio dibasic dodecahydrate

Fosfato de sodio dibasic dodecahydrate puriss. p.a., crystallized, ≥99.0% (T)

Sigma-Aldrich

71650

Fosfato de sodio dibasic dodecahydrate

assay

98.5-102.5%

assay

98.5-102.5% (T)

assay

≥99.0% (T)

assay

≥99.0% (T)

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

crystalline

form

crystals

form

crystals

form

crystals

solubility

water: ~35.8 g/L at 20 °C

solubility

-

solubility

H2O: 0.1 M at 20 °C, clear, colorless

solubility

water: soluble 35.8 g/L at 20 °C

agency

USP/NF, tested according to Ph. Eur.

agency

meets analytical specifications of BP, meets analytical specifications of Ph. Eur.

agency

-

agency

-

Application


  • The gelation behavior of thiolated citrus high-methoxyl pectin induced by sodium phosphate dibasic dodecahydrate.: This research explores how sodium phosphate dibasic dodecahydrate influences the gelation properties of thiolated citrus pectin, showcasing potential applications in food science and pharmaceuticals for controlled gelation processes (Chen J et al., 2022).

  • Use of cellulose nanofibril (CNF)/silver nanoparticles (AgNPs) composite in salt hydrate phase change material for efficient thermal energy storage.: Demonstrates the utility of sodium phosphate dibasic dodecahydrate in enhancing the performance of phase change materials, which are critical for energy storage systems, indicating its role in improving thermal energy storage efficiency (Shen Z et al., 2021).

Clase de almacenamiento

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
BCCN1863
BCCM4949
BCCL9055
BCCL5416
BCCL0807

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Matthew R Weir et al.
Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2
George G S Sandor et al.
International journal of cardiology, 179, 470-475 (2014-12-04)
Patients with Marfan (MFS) and Loeys-Dietz (LDS) syndromes have been shown to have abnormal aortic biophysical properties. The purpose of this study was to compare the effects of 12-months of therapy with atenolol or losartan on vascular function in young
Luciano Candilio et al.
Heart (British Cardiac Society), 101(3), 185-192 (2014-09-26)
Remote ischaemic preconditioning (RIPC), using brief cycles of limb ischaemia/reperfusion, is a non-invasive, low-cost intervention that may reduce perioperative myocardial injury (PMI) in patients undergoing cardiac surgery. We investigated whether RIPC can also improve short-term clinical outcomes. One hundred and
Yuichiro Yano et al.
Journal of the American College of Cardiology, 65(4), 327-335 (2015-01-31)
Isolated systolic hypertension (ISH), defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and middle-aged adults is increasing in prevalence. The aim of this study was to assess the risk
Karen Sliwa et al.
Heart (British Cardiac Society), 100(24), 1967-1974 (2014-09-18)
Lack of evidence-based data on the spectrum of cardiovascular disease (CVD) in pregnancy or in the postpartum period, as well as on maternal and fetal outcome, provides challenges for treating physicians, particularly in areas of low resources. The objectives of
Ver todos los artículos relacionados

Questions

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico